Abilify and Impaired self-care - a phase IV clinical study of FDA data

Summary:

Impaired self-care is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Seroquel, and have Schizophrenia.

The phase IV clinical study analyzes which people have Impaired self-care when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.

What is Impaired self-care?

Impaired self-care is found to be associated with 321 drugs and 443 conditions by eHealthMe. Check the latest studies of Impaired self-care.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 45 people (0.05%) have Impaired self-care.

Among these 45 people:

How long have people been on Abilify when they have Impaired self-care? *

What is the gender of people who have Impaired self-care when taking Abilify? *

female: 50 %
male: 50 %

What is the age of people who have Impaired self-care when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Impaired self-care? *

Memory Loss: 12 people, 26.67%
Tremor (trembling or shaking movements in one or more parts of your body): 12 people, 26.67%
Abnormal Behavior: 11 people, 24.44%
Confusional State: 10 people, 22.22%
Weight Decreased: 10 people, 22.22%
Speech Disorder: 8 people, 17.78%
Gait Disturbance: 8 people, 17.78%
Feeling Abnormal: 7 people, 15.56%
Emotional Distress: 7 people, 15.56%
Crying: 7 people, 15.56%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 11 people, 24.44%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 11.11%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 5 people, 11.11%
Stress And Anxiety: 4 people, 8.89%
Pain: 4 people, 8.89%
Psychotic Disorder: 3 people, 6.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 4.44%
High Blood Pressure: 2 people, 4.44%
Hypersensitivity: 2 people, 4.44%
Cough: 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Impaired self-care?

- Check whether Impaired self-care is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,456 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impaired self-care:

Impaired self-care (321 drugs)

Browse all the conditions that are associated with Impaired self-care:

Impaired self-care (443 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.